氢吗啡酮通过抑制NLRP3炎性小体介导的心肌缺血再灌注损伤保护机制
Mechanisms of Hydromorphone-Mediated Protection Against Myocardial Ischemia-Reperfusion Injury via NLRP3 Inflammasome Inhibition.
作者信息
Zeng Shiyue, Xu Wei, Ren Fangyuan, Xiong Qiangqiang, Qing Qi, Luo Liu, Song Xi, Tan Yurong, Huang Zhujun, Zheng Mingzhi
机构信息
Department of Anesthesiology, Zhuzhou Clinical College, Jishou University, Zhuzhou, Hunan Province, People's Republic of China.
Department of Anesthesiology, Zhuzhou Central Hospital, Zhuzhou, Hunan Province, People's Republic of China.
出版信息
J Inflamm Res. 2025 May 26;18:6853-6863. doi: 10.2147/JIR.S509328. eCollection 2025.
BACKGROUND
Myocardial ischaemia/reperfusion, MI/R injury causes significant cardiac damage, leading to disability and mortality. Although hydromorphone attenuates MI/R injury in rat models, its underlying mechanisms remain unclear.
OBJECTIVE
This study aimed to investigate the protective effects of hydromorphone against MI/R injury and elucidate its mechanisms.
METHODS
A rat MIRI model was established by occluding the left coronary artery for 30 minutes followed by reperfusion for 120 minutes. Infarct size and cardiac function were assessed using hematoxylin-eosin, HE and Masson's staining. An in vitro model was established using H9C2 cells subjected to hypoxia/reoxygenation, and levels of cellular pyroptosis and pyroptosis-related proteins were quantified.
RESULTS
Hydromorphone significantly improved cardiac function in MIRI rats. Pre- and post-treatment with hydromorphone significantly improved cardiomyocyte morphology in MIRI rats. In addition, compared with the model group (IR), the hydromorphone-treated groups (HH+IR, IR+HH) significantly reduced the rna expression of NLRP3, ASC, caspase-1, IL-1β, and IL-18, as well as the protein levels of IL-1β, IL-18. In addition, transmission electron microscopy showed that hydromorphone attenuated CoCl2-induced cardiomyocyte injury.
CONCLUSION
Pre- or post-treatment with hydromorphone exerts protective effects against MIRI by suppressing NLRP3 inflammasomes, potentially providing a theoretical basis for its use as a therapeutic agent in MIRI patients.
背景
心肌缺血/再灌注损伤会导致严重的心脏损害,进而引发残疾和死亡。尽管氢吗啡酮可减轻大鼠模型中的心肌缺血/再灌注损伤,但其潜在机制仍不清楚。
目的
本研究旨在探讨氢吗啡酮对心肌缺血/再灌注损伤的保护作用并阐明其机制。
方法
通过结扎左冠状动脉30分钟后再灌注120分钟建立大鼠心肌缺血/再灌注损伤模型。使用苏木精-伊红染色(HE染色)和Masson染色评估梗死面积和心脏功能。利用缺氧/复氧处理的H9C2细胞建立体外模型,并对细胞焦亡水平和焦亡相关蛋白进行定量分析。
结果
氢吗啡酮显著改善了心肌缺血/再灌注损伤大鼠的心脏功能。氢吗啡酮预处理和后处理均显著改善了心肌缺血/再灌注损伤大鼠的心肌细胞形态。此外,与模型组(IR)相比,氢吗啡酮处理组(HH+IR、IR+HH)显著降低了NLRP3、ASC、半胱天冬酶-1、白细胞介素-1β和白细胞介素-18的RNA表达,以及白细胞介素-1β、白细胞介素-18的蛋白水平。此外,透射电子显微镜显示氢吗啡酮减轻了氯化钴诱导的心肌细胞损伤。
结论
氢吗啡酮预处理或后处理通过抑制NLRP3炎性小体对心肌缺血/再灌注损伤发挥保护作用,这可能为其作为心肌缺血/再灌注损伤患者的治疗药物提供理论依据。